- Home
- IDCC vs ARWR Comparison
IDCC vs ARWR Comparison
Compare IDCC & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDCC
- ARWR
- Stock Information
- Founded
- IDCC 1972
- ARWR 2003
- Country
- IDCC United States
- ARWR United States
- Employees
- IDCC N/A
- ARWR N/A
- Industry
- IDCC Multi-Sector Companies
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- IDCC Miscellaneous
- ARWR Health Care
- Exchange
- IDCC Nasdaq
- ARWR Nasdaq
- Market Cap
- IDCC 6.9B
- ARWR 5.9B
- IPO Year
- IDCC N/A
- ARWR 1993
- Fundamental
- Price
- IDCC $370.67
- ARWR $39.23
- Analyst Decision
- IDCC Strong Buy
- ARWR Strong Buy
- Analyst Count
- IDCC 2
- ARWR 8
- Target Price
- IDCC $412.50
- ARWR $47.75
- AVG Volume (30 Days)
- IDCC 341.9K
- ARWR 1.7M
- Earning Date
- IDCC 10-30-2025
- ARWR 11-25-2025
- Dividend Yield
- IDCC 0.76%
- ARWR N/A
- EPS Growth
- IDCC 58.70
- ARWR N/A
- EPS
- IDCC 14.75
- ARWR N/A
- Revenue
- IDCC $928,587,000.00
- ARWR $572,976,000.00
- Revenue This Year
- IDCC N/A
- ARWR $21,287.22
- Revenue Next Year
- IDCC N/A
- ARWR N/A
- P/E Ratio
- IDCC $25.09
- ARWR N/A
- Revenue Growth
- IDCC 28.75
- ARWR 2816.20
- 52 Week Low
- IDCC $169.58
- ARWR $9.57
- 52 Week High
- IDCC $412.60
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- IDCC 51.71
- ARWR 54.82
- Support Level
- IDCC $368.19
- ARWR $37.56
- Resistance Level
- IDCC $400.00
- ARWR $40.94
- Average True Range (ATR)
- IDCC 19.61
- ARWR 2.11
- MACD
- IDCC -2.43
- ARWR -0.38
- Stochastic Oscillator
- IDCC 29.19
- ARWR 32.32
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.